Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
lugui Qiu, MD
CONTACT
dehui Zou, MD
CONTACT
Lead
Beijing Yongtai Ruike Biotechnology Company Ltd
This trial is a Phase I clinical trial, which is divided into two trial stages. The first stage is a dose-increasing trial stage The second stage is the dose extension experiment stage. The main endpoint is to evaluate its tolerance and safety. The first dose group used rapid titration method for dose increase, and the subsequent dose groups used the classic 3+3 experimental design for dose increase. A total of 4 dose groups are planned to be set up. The second to fourth dose groups will include 3-6 participants in each group
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted